Reflecting Consumer Demand
for Alternatives to High-Calorie, High-Caffeine Energy Drinks

On August 20, Hyundai Pharm announced that its energy drink Enerin has officially entered the convenience store chain 7-Eleven as part of its efforts to expand its sales channels.


Enerin by Hyundai Pharm is a low-calorie energy drink with no added sugar, preservatives, or artificial coloring, making it a beverage that anyone can enjoy without concern.


The Enerin product available at 7-Eleven is a 250ml can, which was launched in May. This product features 'Palatinose,' a natural sugar extracted from honey or sugarcane, and 'guarana extract,' a tropical plant ingredient, both included to create a healthier energy drink.


'Palatinose' is known as a "slow calorie sugar" because it has a low glycemic index and is digested and absorbed more slowly than regular sugar, resulting in less impact on blood sugar spikes and sugar crashes. 'Guarana extract' contains natural caffeine, allowing consumers to enjoy a healthier energy drink experience.


Additionally, the drink contains 2,000mg of taurine, which is known to help with fatigue recovery, as well as a vitamin B complex necessary for energy production in the body.


With Enerin now available at 7-Eleven, Hyundai Pharm expects that its sales channels will become even more diversified, helping to promote its natural energy drink to consumers and continuously increase brand recognition in the energy drink market.



A Hyundai Pharm representative stated, "After launching the 150ml bottle of Enerin for the first time last year and then introducing the 250ml can in May, we decided to expand our lineup and sales channels by entering convenience stores. Since Enerin was developed for consumers who are concerned about high-calorie and high-caffeine energy drinks, we hope that this expansion in sales outlets will allow even more consumers to experience our product."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing